Intrinsic Value of S&P & Nasdaq Contact Us

Mersana Therapeutics, Inc. MRSN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
34/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
-89.7%

Mersana Therapeutics, Inc. (MRSN) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, AMLX, CERE, CGEM, DAWN, HOOK and others.

MRSN has a market capitalization of $145.36M, compared to an average peer market cap of $2.49B. MRSN is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message